BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
IMUC signs option agreement with MD Anderson Cancer Center
-
UTSA adopts Click Commerce’s research, compliance software
-
Sole Finalist Named for UTPA President Position
-
Collaboration creates 250 jobs in Richardson
-
Gophers to Play Texas at TCF Bank Stadium in 2015
-
Tech research at UT in line for $2M in funding
-
University of Texas at Dallas receives 16 gifts worth more than $16.8M
-
RF Code Announces First Ever Wire-Free Liquid Detection Sensor
-
In the race to turn back the biological clock, consumers are reaching for an unproven...
-
TerraTherm, Inc.: TerraTherm Royalty Payments to The University of Texas at Austin Top $1 Million...
News & Analysis
Filter by
agreement and finance and university of texas - All News and Analysis
Cephalon ends Parkinson's study early, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- 2005-05-12
M2 PRESSWIRE-12 May 2005-US Financial Network: Cephalon ends Parkinson's study early, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 City of Industry, CA -...
EDO Corp. acquires EVI Technology , U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- 2005-05-12
M2 PRESSWIRE-12 May 2005-US Financial Network: EDO Corp. acquires EVI Technology , U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 City of Industry, CA...
Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005, U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas.
- 2005-05-12
M2 PRESSWIRE-12 May 2005-US Financial Network: Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005, U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005...
FLIR Systems elects General William W. Crouch -U.S. Army, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- 2005-05-11
M2 PRESSWIRE-11 May 2005-US Financial Network: FLIR Systems elects General William W. Crouch -U.S. Army, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City...
U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas, Forest Laboratories to buy back 25M shares.
- 2005-05-11
M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas, Forest Laboratories to buy back 25M sharesC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of Industry,...
U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, Arena Pharmaceuticals Shares Rise on Study Results.
- 2005-05-11
M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, Arena Pharmaceuticals Shares Rise on Study ResultsC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of...
U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, General Dynamics Awarded $51 Million.
- 2005-05-11
M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, General Dynamics Awarded $51 MillionC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of Industry, CA -...
Norland Medical Systems, Inc. Announces Acquisition Of Worldwide Rights To Proprietary Ultrasound Technology
- 1996-06-04
WHITE PLAINS, N.Y.--BUSINESS WIRE--JUNE 4, 1996--NORLAND MEDICAL SYSTEMS, INC. (NASDAQ: NRLD) announced today it has entered into a distribution agreement with Vitel, Inc., a privately held Texas corporation affiliated with the University of Texas Southwestern Medical Center at Dallas, which is currently developing bone diagnostic devices using the Ultrasound...
- 1
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
